GlassScriptPhysician profile
Robert F Mohr
NPI 1205919065
$5,583.10
in general payments reported to CMS, 2019-2025
32 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $471 · 2021: $971 · 2022: $1,766 · 2023: $535 · 2024: $361 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.70 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $2,709.53 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $424.68 | 2021-2025 | |
| Abbvie INC. | $327.51 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $192.78 | 2021-2025 | Gardasil 9, Gardasil |
| Millicent US INC | $182.11 | 2019-2024 | Femring, Intrarosa |
| Pfizer INC. | $167.26 | 2019-2024 | |
| Therapeuticsmd, INC. | $166.96 | 2019-2022 | |
| Myovant Sciences INC. | $155.34 | 2021-2022 | |
| Exeltis, USA INC. | $155.32 | 2019-2025 | Slynd |
| Exact Sciences Corporation | $140.63 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $101.50 | 2019-2023 | Evenity, Prolia |
| Evofem Biosciences, INC. | $85.29 | 2021-2022 | |
| Davol INC. | $74.75 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $70.16 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $65.98 | 2023-2024 | Myfembree |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $60.84 | 2024-2025 | Jada System |
| Agile Therapeutics, INC. | $60.00 | 2021 | |
| Avion Pharmaceuticals | $57.51 | 2021-2022 | |
| Allergan, INC. | $57.10 | 2019-2020 | |
| Astellas Pharma US INC | $56.33 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $49.05 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.38 | 2022 | |
| Roche Diagnostics Corporation | $34.38 | 2019 | |
| Vertical Pharmaceuticals, LLC | $29.77 | 2019 | |
| Amag Pharmaceuticals, INC. | $28.77 | 2019 | |
| Hologic Sales and Service, LLC | $18.96 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.00 | 2023 | Seglentis |
| Novum Pharma, LLC | $13.79 | 2019 | |
| Duchesnay USA Incorporated | $13.67 | 2019 | |
| Ascend Therapeutics US, LLC | $13.64 | 2022 | |
| Dysis Medical, INC. | $11.11 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mohr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.